BioMatt is a Vice President at Shore Capital, a healthcare private equity firm focused on partnering with companies that have between $1-7 million of EBITDA. Matt’s responsibilities include sourcing, evaluating and enabling the growth of Shore investments. Prior to joining Shore, Matt was an investment professional at Enhanced Healthcare Partners, a healthcare-focused private equity firm in New York. His experience in ....
Education